Immunic, Inc. IMUX
7.60 USD +0.26 (+3.54%)
At closeNov 3, 2026, 4:00 PM EST
7.60 0.00 0.00%
After hours · Nov 3, 4:00 PM ET
7.35 Day range 7.87
5.06 52-week range 17.43
- YTD
- +42.32%
- 1 year
- +1.60%
Analyst view
Price target (mean) 12.79 +68.2% upside
Now 7.60
- Target (low)
- 5.00
- Target (mean)
- 12.79
- Target (high)
- 28.00
Ratings (0m) 7 7 buy · 0 hold · 0 sell
- Strong buy2
- Buy5
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 7
- 1 month ago 6
- 2 months ago 6
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.23857 | -0.26 – -0.22 | -0.48 | +50.3% | 0 | 0.0% | 7 |
| Next quarter | -0.244 | -0.29 – -0.22 | -0.30 | +18.7% | 0 | 0.0% | 5 |
| Current year | -0.96429 | -1.02 – -0.79 | -2.11 | +54.3% | 0 | 0.0% | 7 |
| Next year | -0.76 | -1.03 – -0.40 | -0.96429 | +21.2% | 0 | 0.0% | 7 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 25, 2024 | HC Wainwright & Co. | Initiated | — | Buy |
| Nov 7, 2024 | EF Hutton | Maintained | Buy | Buy |
| Oct 22, 2024 | EF Hutton | Maintained | Buy | Buy |
| Sep 18, 2024 | EF Hutton | Maintained | Buy | Buy |
| Sep 16, 2024 | EF Hutton | Initiated | — | Buy |
| Aug 27, 2024 | B. Riley Securities | Initiated | — | Buy |
| Jul 16, 2024 | Piper Sandler | Reiterated | Overweight | Overweight |
| Apr 5, 2024 | Brookline Capital | Initiated | — | Buy |
| Oct 10, 2023 | Wedbush | Maintained | Outperform | Outperform |
| Jul 27, 2023 | Wedbush | Reiterated | Outperform | Outperform |
| Oct 21, 2022 | SVB Leerink | Downgrade | Outperform | Market Perform |
| Aug 8, 2022 | Aegis Capital | Maintained | — | Buy |
| Jun 3, 2022 | SVB Leerink | Maintained | — | Outperform |
| May 18, 2022 | Piper Sandler | Maintained | — | Overweight |
| Sep 7, 2021 | HC Wainwright & Co. | Maintained | — | Buy |
| Apr 15, 2021 | Aegis Capital | Initiated | — | Buy |
| Mar 24, 2021 | JMP Securities | Initiated | — | Market Outperform |
| Oct 2, 2020 | SVB Leerink | Initiated | — | Outperform |
| Aug 26, 2020 | Piper Sandler | Initiated | — | Overweight |
| Aug 21, 2020 | HC Wainwright & Co. | Maintained | — | Buy |
| Aug 3, 2020 | HC Wainwright & Co. | Maintained | — | Buy |
| Jul 20, 2020 | BMO Capital | Initiated | — | Outperform |
| Jun 5, 2020 | Wedbush | Initiated | — | Outperform |
| May 11, 2020 | HC Wainwright & Co. | Initiated | — | Buy |
| Aug 12, 2019 | Chardan Capital | Initiated | — | Buy |
| Jul 11, 2019 | Chardan Capital | Initiated | — | Buy |